---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-26-000050"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2026-06-05T20:50:44+00:00"
generated_at: "2026-06-05T20:52:06.730381+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners annual meeting: all director nominees re-elected, say-on-pay and auditor ratified

## Summary
- Class II directors Devin O'Reilly, Brent Turner, and Laura L. Forese re-elected with >90M votes for each.
- Advisory vote on executive compensation approved: 111.6M for, 2.0M against, 15K abstentions.
- Ratification of Ernst & Young as independent auditor for FY 2026 approved: 119.8M for, 62.9K against.

## SEC filing metadata
- accession: 0001638833-26-000050
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2026-06-05T20:50:44+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000050/0001638833-26-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000050/sgry-20260605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-26-000050
- JSON: https://secwatch.observer/filing/0001638833-26-000050.json
- Plain text: https://secwatch.observer/filing/0001638833-26-000050.txt

## Key facts
- Shareholder Votes
  Surgery Partners, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-06-05 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000050/0001638833-26-000050-index.htm
- Shareholder Votes
  Surgery Partners, Inc. shareholders approved Election of Class II directors at the 2026-06-05 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: The stockholders elected each of the director nominees to serve as a Class II director until the Company’s 2029 annual meeting of stockholders and until each such successor has been elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000050/0001638833-26-000050-index.htm
- Shareholder Votes
  Surgery Partners, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-05 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: The stockholders approved on a non-binding, advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 23, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000050/0001638833-26-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.